Pharmaceutical microbiology's main objective is to ensure the safety and efficacy of pharmaceutical goods. It includes procedures such as disinfectant validation, study of disinfection efficacy in suspension, on surfaces, and in field trials. It focuses on the causes of pharmaceutical contamination (microbe contamination of medicinal products) and spoilage. Pharmaceutical microbiologists place a strong emphasis on quality control to ensure that life-saving medications and vaccines are free of microorganism contamination.
Pharmaceutical Biotechnology (PB) is focused on the development of pharmaceuticals, treatments, and vaccines to treat human diseases. It is the investigation of biopharmaceuticals from conception to delivery. Pharmaceutical biotechnology is becoming a more essential field of science and technology, as it aids in the discovery of novel therapeutic medications, the production of diagnostic agents for medical testing, and the beginnings of gene therapy for the treatment of genetic disorders' medical symptoms.
- Controlled environments
- Antimicrobial activity
- Microbiology
- Molecular biology
- Biochemistry
- Genetics
John K Maesaka
NYU Langone Hospital Long Island, United States
Consolato M Sergi
University of Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Bernd Blobel
University of Regensburg, GermanySubmit your abstract Today
Title : Liver biopsy handling of Metabolic-Associated Fatty Liver Disease (MAFLD): The children's hospital of eastern Ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada
Title : Haptoglobin-Related Protein Without Signal Peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States
Title : Revolutionizing healthcare and pharma: Artificial intelligence-powered scientific communications and medical writing
Alessandro Gallo, Springer Healthcare, Italy
Title : Enabling knowledge-driven integration and interoperability in intelligent and ethical transformed health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign-driven biotech and upgraded biomarketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Integration of nanotechnology into complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Combating aluminium chloride-induced alzheimer's in rats: Neuroprotective effects of Nelumbo nucifera and Bergenia ligulate
Nilay Solanki, Ramanbhai Patel College of Pharmacy, India
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, East Tennessee State University, United States
Title : Ayurvedic bhasmas as a nano medicines for the human kind
Prashant Sakharam Bhokardankar, Datta Meghe Ayurved College, Hospital & Research Centre, India